Cadrenal Therapeutics, Inc. Contracts & Agreements
54 Contracts & Agreements
- Business Finance (32 contracts)
- Business Operations (1)
- Human Resources (16)
- Intellectual Property (1)
- Uncategorized (4)
- Form of Warrant Inducement Agreement (Filed With SEC on November 4, 2024)
- Form of Placement Agent Warrant (Filed With SEC on November 4, 2024)
- Form of New Warrant (Filed With SEC on November 4, 2024)
- Amendment to the Cadrenal Therapeutics, Inc. 2022 Successor Equity Incentive Plan (Filed With SEC on July 31, 2024)
- At the Market Offering Agreement by and between Cadrenal Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 12, 2024)
- Employment Agreement, effective as of February 8, 2024, between Cadrenal Therapeutics, Inc. and Jeffrey Cole (Filed With SEC on February 12, 2024)
- Offer Letter dated, February 6, 2024, between Cadrenal Therapeutics, Inc. and Jeffrey Cole (Filed With SEC on February 12, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on July 14, 2023)
- Form of Warrant (Filed With SEC on July 14, 2023)
- Form of Placement Agent Warrant (Filed With SEC on July 14, 2023)
- Form of Registration Rights Agreement by and between Cadrenal Therapeutics, Inc. and the purchaser party thereto (Filed With SEC on July 14, 2023)
- Form of Lock-Up Agreement (Filed With SEC on July 14, 2023)
- Form of Securities Purchase Agreement, dated July 12, 2023, by and between Cadrenal Therapeutics, Inc. and the purchaser party thereto (Filed With SEC on July 14, 2023)
- Amendment No. 1 to Employment Agreement by and between Cadrenal Therapeutics, Inc. and Matthew Szot, dated May 25, 2023 (Filed With SEC on May 26, 2023)
- Description of Securities (Filed With SEC on March 30, 2023)
- Amendment to Asset Purchase Agreement, dated as of August 18, 2022, between the Company and HESP LLC (Filed With SEC on January 25, 2023)
- Underwriting Agreement, dated January 19, 2023, by and between Cadrenal Therapeutics, Inc. and Boustead Securities, LLC (Filed With SEC on January 25, 2023)
- Representatives Warrant issued to Boustead Securities, LLC, dated January 19, 2023 (Filed With SEC on January 25, 2023)
- Form of Indemnification Agreement (Filed With SEC on January 25, 2023)
- Employment Agreement, dated January 24, 2023, by and between Cadrenal Therapeutics, Inc. and Matthew Szot (Filed With SEC on January 25, 2023)
- Employment Agreement, effective as of January 24, 2023, by and between Cadrenal Therapeutics, Inc. and Douglas Losordo (Filed With SEC on January 25, 2023)
- Form of Underwriting Agreement by and between Cadrenal Therapeutics, Inc. and Boustead Securities,LLC, as representative of the underwriters (Filed With SEC on December 8, 2022)
- Form of November Private Placement Promissory Note (Filed With SEC on December 6, 2022)
- Form of Amendment to Convertible Promissory Note (Filed With SEC on December 6, 2022)
- Form of Placement Agent Warrant from November Private Placement (Filed With SEC on December 6, 2022)
- Form of Amended and Restated Placement Agent Warrant from Private Placement (Filed With SEC on December 6, 2022)
- Form of Amended and Restated November Warrant (Filed With SEC on December 6, 2022)
- Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2022 Successor Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the 2022 Successor Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Cadrenal Therapeutics, Inc. 2022 Successor Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the 2022 Amended and Restated Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Cadrenal Therapeutics, Inc. 2022 Amended and Restated Equity Incentive Plan (Filed With SEC on October 17, 2022)
- Form of Underwriting Agreement by and between Cadrenal Therapeutics, Inc. and Boustead Securities,LLC, as representative of the underwriters (Filed With SEC on October 17, 2022)
- Form of Representatives Warrant Agreement (Filed With SEC on October 11, 2022)
- Form of Underwriting Agreement by and between Cadrenal Therapeutics, Inc. and Boustead Securities,LLC, as representative of the underwriters (Filed With SEC on October 11, 2022)
- Specimen Common Stock Certificate (Filed With SEC on October 11, 2022)
- Form of Placement Agent Warrant (Filed With SEC on October 11, 2022)
- License, Development and Commercialization Agreement Effective as of September 16, 2015 by and between Armetheon, Inc. and China Cardiovascular Focus Ltd (Filed With SEC on October 11, 2022)
- Form of Convertible Note dated June13, 2022 (Filed With SEC on September 22, 2022)
- Convertible Promissory Note dated March1, 2022 issued to John Murphy (Filed With SEC on September 22, 2022)
- Form of Private Placement Convertible Note (Filed With SEC on September 22, 2022)
- Form of Placement Agent Warrant (Filed With SEC on September 22, 2022)
- Cadrenal Therapeutics, Inc. 2022 Equity Incentive Plan and form of Incentive Stock Option Agreement, Non-Qualified Stock Option Agreement for Officers and Other Employees,... (Filed With SEC on September 22, 2022)
- Consulting Agreement, dated January 25, 2022, with Phamace LLC (Quang Pham) from company formation until initiation of payroll (Filed With SEC on September 22, 2022)
- Employment Agreement, dated March1, 2022 with Quang Pham (Filed With SEC on September 22, 2022)
- Consulting Agreement, dated May 17, 2022, with Matthew Szot (Filed With SEC on September 22, 2022)
- Restricted Stock Purchase Agreement with Matthew Szot (Filed With SEC on September 22, 2022)
- Form of Employment Agreement to be entered into with Matthew Szot (Filed With SEC on September 22, 2022)
- Asset Purchase Agreement dated as of April1, 2022, between Cadrenal Therapeutics, Inc. and HESP LLC (Filed With SEC on September 22, 2022)
- Patent Assignment Agreement dated as of April1, 2022, between Cadrenal Therapeutics, Inc. and HESP LLC (Filed With SEC on September 22, 2022)
- Subscription Agreement with Quang Pham, dated January 25, 2022 (Filed With SEC on September 22, 2022)
- Form of Investor Rights and Lockup Agreement (Filed With SEC on September 22, 2022)
- Amendment to Asset Purchase Agreement, dated as of August 18, 2022, between Cadrenal Therapeutics, Inc. and HESP LLC (Filed With SEC on September 22, 2022)
- Form of Employment Agreement to be entered into with Douglas Losordo (Filed With SEC on September 22, 2022)
